Searched for
PHARMEASY THYROCARE
Pharmeasy founder Siddharth Shah steps down as CEOPharmeasy founder Siddharth Shah has stepped down as the chief executive to assume the role of vice chairman of the company's board. Rahul ...- Goldman may convert part-debt into equity in PharmEasyThe online pharmacy is also in talks to restructure debt terms ahead of rights issue; share sale set to open on September 4
- PharmEasy valuation crash may not hit Thyrocare founder Velumani’s stakePharmEasy is faced with a steep cut in its valuation, with the new funding round pegging its shares at Rs 5 each compared to the Rs 50 per ...
- Exclusive | Not selling Thyrocare, will cut cash burn: PharmEasy founders to boardPharmEasy’s parent API Holdings has also delayed internal plans for a potential initial public offering (IPO) to 2025, the people privy to ...
- PharmEasy in talks to raise upto $300 million, valuation may drop by halfExisting investors will also put in $70 million, valuation at $2.5-$2.75 versus $5.4 billion of last year’s pre-IPO round. IPO is shelved f...
- PharmEasy pulls out market listing planThe company will consider raising funds via rights issue, reported CNBC. API Holdings rights issue will have Compulsory Convertible Prefere...
- PharmEasy plans $200 million fund raising at lower valuationPharmEasy's planned fund raising is set to see participation from some existing investors, who have indicated they will commit about $115 m...
- Thyrocare to stay focused on volumes, on time performance & qualityThe company is investing heavily on improving turnaround time and addressing quality perception of the brand in the market through a combin...
- Watch out for these factors in Thyrocare as closely as you would watch any symptoms!Through strategic acquisitions in the healthcare space, the company seems to be aiming to create “a holistic healthcare ecosystem”. From th...
- Buy Thyrocare Technologies, target price Rs 1310: HDFC SecuritiesThyrocare Technologies Ltd., incorporated in the year 2000, is a Mid Cap company (having a market cap of Rs 5758.02 Crore) operating in Hos...
- PharmEasy parent API Holdings files papers for Rs 6,250 crore IPOAPI Holdings, the parent of online pharmacy PharmEasy, has filed its draft red herring prospectus (DRHP) with market regulator Sebi for a ₹...
- PharmEasy plans to file IPO papers by OctoberPharmEasy is on track for an IPO but is still negotiating with new investors to raise between $200 million and $300 million at a valuation ...
- Pharmeasy in funding talks with SoftBank after Thyrocare dealPharmeasy’s parent API Holdings is seeking a valuation of at least $5.6 billion in a new funding round. SoftBank could invest $150 million ...
- It was the right time and right way to exit, Thyrocare's A Velumani saysArokiaswamy Velumani, who quit a government job at the Bhabha Atomic Research Centre to start Thyrocare in 1995, on why he decided to sell ...
- Thyrocare set for fast track with PharmEasyThyrocare is primarily a B2B diagnostic services provider. With PharmEasy’s presence, it will no longer be seen as a conventional diagnosti...
- PharmEasy buyout puts Thyrocare in a different league: AnalystsThyrocare is making efforts to bolster its brand visibility through the opening of regional and zonal reference laboratories and branded co...
- ETtech Exclusive: PharmEasy gets $300 million booster shot for Thyrocare dealPharmEasy has raised $300 million more, bringing the total funding received by the online pharmacy since April to $650 million, most of whi...
- PharmEasy to acquire 66% stake in Thyrocare for over Rs 4,500 crorePharmEasy is acquiring a majority stake in diagnostics chain Thyrocare Technologies, in what the online pharmacy claimed was the first ever...
- PharmEasy to acquire 66% stake in Thyrocare Tech, to make open offer to grab additional 26%PharmEasy claims to be India’s number one online pharmacy and diagnostics brand. Thyrocare prides itself as the largest diagnostic company.
- PharmEasy to acquire ThyrocareFrom Pharmeasy-Thyrocare deal to Twitter briefly locking IT minister's account and China's role in 2021's crypto collapse, here's a quick l...
Load More
